150 related articles for article (PubMed ID: 7875162)
1. Diagnostic histologic criteria of atypical adenomatous hyperplasia and well differentiated adenocarcinoma of the endometrium.
Liapis A; Pafitis A; Hassiakos D; Chirakis M; Zourlas PA
Eur J Gynaecol Oncol; 1994; 15(6):464-8. PubMed ID: 7875162
[TBL] [Abstract][Full Text] [Related]
2. Endometrial hyperplasia/adenocarcinoma. a conventional approach.
Mazur MT
Ann Diagn Pathol; 2005 Jun; 9(3):174-81. PubMed ID: 15944963
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
4. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
5. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
[TBL] [Abstract][Full Text] [Related]
6. Endometrial brush cytology of advanced postmenopausal endometrium: does endometrial intraepithelial neoplasia exist in the absence of hyperplasia?
Maksem JA
Diagn Cytopathol; 1998 Nov; 19(5):338-43. PubMed ID: 9812226
[TBL] [Abstract][Full Text] [Related]
7. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
McKenney JK; Longacre TA
Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
[TBL] [Abstract][Full Text] [Related]
8. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
9. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.
Kendall BS; Ronnett BM; Isacson C; Cho KR; Hedrick L; Diener-West M; Kurman RJ
Am J Surg Pathol; 1998 Aug; 22(8):1012-9. PubMed ID: 9706982
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia.
Shutter J; Wright TC
Int J Gynecol Pathol; 2005 Oct; 24(4):313-8. PubMed ID: 16175074
[TBL] [Abstract][Full Text] [Related]
12. A karyometric approach to the characterization of atypical endometrial hyperplasia with and without co-occurring adenocarcinoma.
Garcia FA; Davis JR; Alberts DS; Liu Y; Thompson D; Bartels PH
Anal Quant Cytol Histol; 2003 Dec; 25(6):339-46. PubMed ID: 14714300
[TBL] [Abstract][Full Text] [Related]
13. [Histochemical characterization of endometrial proliferation using AgNOR (nucleolus organizer region)].
Brustmann H; Riss P; Naudé S
Gynakol Geburtshilfliche Rundsch; 1994; 34(4):220-2. PubMed ID: 7819777
[TBL] [Abstract][Full Text] [Related]
14. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
15. [Endometrial hyperplasia and carcinoma in situ].
Ganchev S; Maĭnkhard K
Akush Ginekol (Sofiia); 1997; 36(3):47-50. PubMed ID: 9618961
[TBL] [Abstract][Full Text] [Related]
16. [Hysteroscopic diagnosis and follow-up of adenomatous hyperplasia and therapeutic consequences].
Schmidt T; Römer T; Schwesinger G; Lorenz G
Zentralbl Gynakol; 1997; 119(1):12-5. PubMed ID: 9133142
[TBL] [Abstract][Full Text] [Related]
17. Nuclear chromatin patterns in normal, hyperplastic and atypical endometrium.
Garcia FA; Davis JR; Alberts DS; Hatch K; Weyn B; Thompson D; Bartels PH
Anal Quant Cytol Histol; 2001 Apr; 23(2):144-50. PubMed ID: 11332081
[TBL] [Abstract][Full Text] [Related]
18. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
19. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.
Ashton-Sager A; Paulino AF; Afify AM
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788
[TBL] [Abstract][Full Text] [Related]
20. Digital morphometry of cytologic aspirate endometrial samples.
Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
